Eisai will launch the Eisai Center for Genetics Guided Dementia Discovery, which will harness the power of human genetics to develop next-generation medicines for Alzheimer’s disease (AD) and other dementias. Guided by emerging insights from human genetics, coupled with Eisai’s recognized strengths in neuroscience and novel chemistry, the Center will specialize in immunodementia drug discovery.…